BNGO Bionano Genomics, Inc. Stock Quote

BNGO [NASD]

Healthcare | Diagnostics & Research | USA

Index	-	P/E	-	EPS (ttm)	-0.33	Insider Own	2.00%	Shs Outstand	284.61M	Perf Week	-17.28%
Market Cap	371.39M	Forward P/E	-	EPS next Y	-0.37	Insider Trans	0.18%	Shs Float	284.15M	Perf Month	-14.65%
Income	-92.40M	PEG	-	EPS next Q	-0.09	Inst Own	25.80%	Short Float	13.62%	Perf Quarter	-48.06%
Sales	20.50M	P/S	18.12	EPS this Y	33.60%	Inst Trans	-4.39%	Short Ratio	6.00	Perf Half Y	-57.05%
Book/sh	1.09	P/B	1.23	EPS next Y	5.10%	ROA	-25.60%	Target Price	8.67	Perf Year	-80.35%
Cash/sh	0.78	P/C	1.72	EPS next 5Y	-	ROE	-27.70%	52W Range	1.16 - 7.31	Perf YTD	-55.18%
Dividend	-	P/FCF	-	EPS past 5Y	33.30%	ROI	-21.00%	52W High	-81.67%	Beta	2.18
Dividend %	-	Quick Ratio	12.10	Sales past 5Y	21.50%	Gross Margin	18.00%	52W Low	15.52%	ATR	0.12
Employees	299	Current Ratio	13.00	Sales Q/Q	78.10%	Oper. Margin	-	RSI (14)	40.57	Volatility	7.75% 7.60%
Optionable	Yes	Debt/Eq	0.01	EPS Q/Q	-179.20%	Profit Margin	-	Rel Volume	0.90	Prev Close	1.38
Shortable	Yes	LT Debt/Eq	0.01	Earnings	May 05 AMC	Payout	-	Avg Volume	6.46M	Price	1.34
Recom	1.30	SMA20	-11.67%	SMA50	-15.30%	SMA200	-55.02%	Volume	5,837,423	Change	-2.90%

Jun-16-21

Initiated

BTIG Research

Buy

$10

Sep-24-20

Initiated

Ladenburg Thalmann

Buy

$1.25

Apr-08-20

Initiated

Oppenheimer

Outperform

$1.50

Jun-29-22 08:00AM	Bionano Genomics Announces Issuance of a U.S. Patent for Analysis of Small Nucleic Acid Fragments in Nanochannel Arrays GlobeNewswire
Jun-16-22 08:00AM	Bionano Genomics Announces Participation at the European Association for Cancer Research (EACR) Congress 2022 Featuring OGM Applications for Cancer Research GlobeNewswire
Jun-10-22 08:00AM	Bionano Genomics Announces Participation at the European Society of Human Genetics Conference (ESHG) 2022 Featuring OGM Across a Broad Range of Clinical Research Applications and a Collaborative Product Development with Hamilton GlobeNewswire -7.41%
Jun-09-22 09:00AM	Hamilton and Bionano Genomics Announce Worlds First Ultra High Molecular Weight DNA Extraction Automation Solution for OGM GlobeNewswire
Jun-08-22 08:00AM	Bionano Genomics Announces Publication of a New Study Using OGM to Investigate Inversions that May Lead to Genetic Disorders GlobeNewswire
Jun-03-22 08:00AM	Bionano Genomics Announces Canadian College of Medical Geneticists Presentation Featuring Applications of OGM for Genetic Research GlobeNewswire
Jun-02-22 08:00AM	Bionano Genomics Announces Participation at the Advances in Genome Biology and Technology (AGBT) General Meeting 2022 GlobeNewswire +9.55%
May-26-22 07:39PM	Bionano Announces Glass Lewis Recommendation and Encourages Stockholders to Cast their Vote Ahead of June 9th Annual Meeting GlobeNewswire
08:00AM	First Published Study of OGM in Pediatric AML Shows OGM Identifies MRD Markers and other Novel Variants that Can Impact Case Management GlobeNewswire
May-17-22 04:05PM	Bionano Genomics to Present at the 2022 H.C. Wainwright Global Investment Conference GlobeNewswire +7.01%
May-13-22 08:00AM	Bionano Genomics Announces Participation at the 2022 American Cytogenomics Conference (ACC) and a User Spotlight Event at Augusta University, a Center of Excellence for OGM GlobeNewswire +14.89%
May-12-22 08:00AM	Bionano Genomics Announces a Publication From the First Affiliated Hospital of Zhengzhou Highlighting the Utility of OGM GlobeNewswire +15.10%
May-07-22 10:01AM	Shareholders in Bionano Genomics (NASDAQ:BNGO) are in the red if they invested a year ago Simply Wall St.
May-06-22 01:30AM	Bionano Genomics, Inc (BNGO) Q1 2022 Earnings Call Transcript Motley Fool -7.14%
May-05-22 06:05PM	Bionano Genomics, Inc. (BNGO) Reports Q1 Loss, Tops Revenue Estimates Zacks -9.68%
04:01PM	Bionano Genomics Reports First Quarter 2022 Financial Results and Highlights Recent Business Progress GlobeNewswire
Apr-29-22 08:00AM	Bionano Genomics Announces Peer-Reviewed Publication of NeuroSCORE Model to Predict and Prioritize Human Genes Contributing to Neurodevelopmental Disease GlobeNewswire
Apr-28-22 04:30PM	Bionano Genomics to Report First Quarter 2022 Financial Results and Host a Conference Call and Webcast on May 5, 2022 GlobeNewswire
Apr-27-22 05:06AM	3 Moonshot Stocks With Upside of Up to 709%, According to Wall Street Motley Fool
Apr-14-22 08:00AM	Bionano Genomics Announces Issuance of Two U.S. Patents for Novel Methods that Expand Patent Protection for Uses of Nanochannel Arrays in Genome Analysis GlobeNewswire
Apr-11-22 11:51AM	The Latest Studies by Bionano Genomics Are Promising, But Its Not a Buy Yet InvestorPlace -5.45%
Apr-08-22 02:19PM	Bionano: Important Catalysts Ahead Should Strengthen Value Proposition TipRanks -5.17%
Apr-07-22 08:00AM	Bionano Genomics Announces Release of Version 6.2 of its NxClinical Software with Significant New Capabilities for Cancer Research Applications Including HRD Analysis GlobeNewswire
Apr-06-22 08:00AM	Bionano Genomics Announces Publication of a New Study Using OGM Combined with Multiple Analytical Methods Including Single-Cell Analysis as a Comprehensive Molecular Strategy to Characterize the Genomic Variation in B-cell Acute Lymphoblastic Leukemia GlobeNewswire -6.95%
Apr-05-22 08:00AM	Bionano Genomics Announces Participation at the American Association for Cancer Research Annual Meeting Spotlighting Optical Genome Mapping Applications and Enhanced NxClinical Capabilities for Cancer Research GlobeNewswire -5.13%
Apr-01-22 08:35AM	Why Bionano Genomics Stock Is Risky, but a Good Bet InvestorPlace
Mar-26-22 06:55AM	3 No-Brainer Stocks to Buy Right Now for Less Than $6 Motley Fool
Mar-25-22 08:00AM	Bionano Genomics Announces Speaker Lineup for 2022 China Symposium GlobeNewswire
Mar-23-22 04:14PM	Bionano Genomics to Present at the 2022 Maxim Virtual Growth Conference GlobeNewswire
08:00AM	Bionano Genomics Announces its Participation at the American College of Medical Genetics and Genomics Annual Clinical Genetics Meeting with Six Posters and All of its On-Market Solutions on Display GlobeNewswire
Mar-22-22 07:00AM	Bionano Genomics Stock Can Regain the Crucial $5 Level InvestorPlace +5.26%
Mar-19-22 10:23AM	Is Bionano Genomics a Buy? Motley Fool
Mar-18-22 06:49PM	Bionano Genomics May Finally Offer a Reward for Your Risk InvestorPlace +9.35%
08:00AM	Bionano Genomics Announces Publication of Comprehensive Validation of Optical Genome Mapping for Hematologic Neoplasms GlobeNewswire
Mar-08-22 05:00PM	Bionano Genomics to Present at the 32nd Annual Oppenheimer Healthcare Conference GlobeNewswire
06:23AM	Hold On to Bionano Genomics Stock Until It Reaches $6 at Least InvestorPlace
Mar-07-22 08:00AM	Bionano Genomics Appoints Dr. Aleks Rajkovic to its Board of Directors GlobeNewswire
Mar-03-22 04:38PM	Bionano Genomics to Present at the 42nd Annual Cowen Healthcare Conference GlobeNewswire -8.29%
Mar-01-22 08:30PM	Bionano Genomics, Inc (BNGO) Q4 2021 Earnings Call Transcript Motley Fool
04:05PM	Bionano Genomics Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Revenue Outlook for 2022 GlobeNewswire
Feb-28-22 08:00AM	Bionano Genomics Announces Launch of Its Rare Undiagnosed Genetic Disease (RUGD) Strategic Initiative Aimed at the 350 Million People Globally Living with a Rare Disease GlobeNewswire
Feb-24-22 04:29PM	Bionano Genomics Has Attractive Applications But An Unattractive Stock Price InvestorPlace +14.05%
05:12AM	Companies Like Bionano Genomics (NASDAQ:BNGO) Are In A Position To Invest In Growth Simply Wall St.
Feb-22-22 04:30PM	Bionano Genomics to Report Fourth Quarter and Year End 2021 Financial Results and Host a Conference Call and Webcast on March 1st, 2022 GlobeNewswire
08:00AM	Bionano Genomics Announces Publication of Prospective Study Demonstrating Performance Improvements from OGM in the Analysis of AML and MDS Compared to Traditional Methods GlobeNewswire
Feb-17-22 06:00AM	Bionano Stock Looks to Have a Monster Comeback in Its Future InvestorPlace -8.11%
Feb-15-22 02:43PM	Bionano Stock Retains Its Strong Buy Status TipRanks +6.34%
Feb-14-22 08:00AM	Bionano Genomics Appoints Helene Klein as its First Ever Chief People Officer GlobeNewswire -6.39%
Feb-11-22 08:00AM	Bionano Genomics Announces First Publication Demonstrating OGM as an Alternative to Karyotyping for Product of Conception Sample Analysis GlobeNewswire -6.41%
Feb-09-22 04:30PM	Bionano Genomics to Present at the 2022 BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference GlobeNewswire +7.17%
Feb-07-22 02:12PM	Investors Have Cast Their No Votes Against Bionano Genomics InvestorPlace
Feb-04-22 02:04PM	Bionano Is Not the Genomics Stock To Bet On InvestorPlace
Feb-03-22 01:38PM	Inspire Investing, LLC Buys Inspire Tactical Balanced ESG ETF, Inspire Small/Mid Cap Impact ... GuruFocus.com -7.62%
Feb-02-22 08:00AM	Bionano Genomics Announces UK Footprint Expansion with Adoption of its Saphyr® System for Optical Genome Mapping in Two Genetic Laboratory Hubs within the United Kingdoms National Health Service GlobeNewswire
Jan-29-22 05:51AM	4 Under-the-Radar Stocks With 319% to 645% Upside in 2022, According to Wall Street Motley Fool
Jan-26-22 08:00AM	Bionano Genomics Announces Publication of the First Study to Combine OGM and NGS to Evaluate Myeloid Cancers GlobeNewswire
Jan-25-22 03:45PM	Bionano Genomics Is Interesting as Genome Testing Scales Upwards InvestorPlace
Jan-20-22 08:00AM	Bionano Genomics Announces Publication by International COVID-19 Host Genome Structural Variation Consortium Describing How OGM Identified Structural Variations as Predisposing Factors Associated with Severe COVID-19 GlobeNewswire
Jan-19-22 10:51PM	UPDATE -- Bionano Genomics Announces its Support for the ACMG Foundation for Genetic and Genomic Medicine and its Next Generation Fellowship & Residency Training Awards Program GlobeNewswire
09:36PM	Bionano Genomics Announces its Support for the AGMG Foundation for Genetic and Genomic Medicine and its Next Generation Fellowship & Residency Training Awards Program GlobeNewswire
08:00AM	Bionano Genomics Announces Record Daily Attendance for 2022 Symposium with 63% Increase Relative to Last Year GlobeNewswire
Jan-13-22 09:40PM	New Developments Bode Well for Bionano Stock, Says Analyst TipRanks -8.63%
06:18PM	Bionano Genomics Hosts Final Day of 2022 Symposium with Presentations Demonstrating the Combined Detection Power of OGM and NGS GlobeNewswire
Jan-12-22 04:30PM	Bionano Genomics Hosts Day 3 of 2022 Symposium with New Research Demonstrating Applications of OGM in Solid Tumor Analysis GlobeNewswire
12:15PM	Bionano Genomics Preliminary Q4, FY21 Revenue Exceed Expectations Benzinga
08:00AM	Bionano Genomics Reports Preliminary Fourth Quarter and Full-Year 2021 Results GlobeNewswire
Jan-11-22 05:11PM	Bionano Genomics Hosts Day 2 of 2022 Symposium with New Research Demonstrating How OGM Detects Known and Novel Variants in Hematologic Malignancies GlobeNewswire
Jan-10-22 07:48PM	UPDATE - Bionano Genomics Hosts Day 1 of 2022 Symposium with Six Presentations Highlighting the Superior Performance of OGM in Variant Detection for Constitutional Genetic Diseases GlobeNewswire
06:26PM	Bionano Genomics Hosts Day 1 of 2022 Symposium with Six Presentations Highlighting the Superior Performance of OGM in Variant Detection for Constitutional Genetic Diseases GlobeNewswire
08:00AM	Bionano Genomics Announces Publication of Interim Readout from the Consortium Conducting a Postnatal Clinical Trial Intended to Support Establishing Optical Genome Mapping as Part of Standard of Care in Genetic Disease Diagnosis GlobeNewswire
Jan-07-22 08:00AM	Bionano Genomics Announces the Final Speaker Lineup for 2022 Symposium GlobeNewswire
Jan-03-22 03:33PM	Bionano Genomics Stock Is a Low-Priced Bet on Sound Science InvestorPlace +8.03%
Dec-29-21 08:00AM	Bionano Announces Prototype for its Next Single Molecule Imaging System for OGM GlobeNewswire
Dec-28-21 03:42PM	Why Bionano Stock Is Underappreciated, According to Oppenheimer TipRanks -7.66%
Dec-27-21 06:00AM	The Critics Are Wrong About Bionano Stock InvestorPlace
Dec-23-21 08:00AM	University Hospitals Leuven in Belgium Outlines their Menu Expansion Plans for Optical Genome Mapping as One of their Primary Analyses in Leukemias & Lymphomas and Genetic Disease GlobeNewswire
Dec-22-21 08:05PM	Bionano Genomics Appoints Vince Wong to its Board of Directors GlobeNewswire
Dec-16-21 08:00AM	Bionano Genomics Announces the Launch of Version 6.1 of BioDiscoverys NxClinical Software for Genome Analysis with Expanded Capabilities for Visualization, Interpretation and Reporting of Next-Generation Sequencing Data in Genetic Diseases and Cancer GlobeNewswire
Dec-14-21 10:35AM	This Analysts Saphyr Calculations Suggest Buying Bionano While Its Down InvestorPlace
Dec-10-21 10:34AM	Oppenheimer Pounds the Table on Bionano Stock TipRanks
08:42AM	Do Options Traders Know Something About Bionano (BNGO) Stock We Don't? Zacks
Dec-09-21 08:00AM	Bionano Genomics Announces 2022 Symposium Featuring Four Consecutive Days of OGM Presentations and Live Panel Discussions Delivered by 25 Different Customers Across a Wide Range of Genetic Disease and Cancer Applications GlobeNewswire -5.63%
Dec-08-21 08:00AM	Bionano Genomics Announces Publication of Study Evaluating Optical Genome Mapping for High Throughput Characterization of Cytogenomic Heterogeneity in MDS GlobeNewswire
Dec-03-21 03:18PM	Jim Cramer is Bearish on These 10 Stocks Insider Monkey -8.36%
Dec-01-21 06:00AM	Bionano Genomics Proves Not Everything Genetic is Gold InvestorPlace -5.37%
Nov-29-21 10:00AM	3 Incredibly Cheap Growth Stocks That Could Make You a Millionaire Motley Fool
08:00AM	Bionano Genomics Appoints Dr. Keith Gligorich, Seasoned Leader in CLIA-Certified CAP-Accredited Lab Operations, as VP Operations for Bionano Laboratories GlobeNewswire
Nov-23-21 05:21PM	Wait for Bionano Stock to Fall Further Before Buying InvestorPlace
Nov-22-21 08:00AM	Bionano Genomics Announces Peer-Reviewed Publication from Johns Hopkins University Outlining a Stepwise Approach to the Adoption of Optical Genome Mapping for Cancer Analysis GlobeNewswire
Nov-19-21 02:54PM	Bionanos Is on Track for Growth Thanks to Saphyr InvestorPlace
Nov-15-21 08:00AM	Bionano Genomics Announces Extensive Lineup of Content to be Presented at the Annual Meeting of the Association for Molecular Pathology Featuring Optical Genome Mapping Across a Broad Range of Clinical Research Applications GlobeNewswire
Nov-06-21 01:31AM	Bionano Genomics, Inc (BNGO) Q3 2021 Earnings Call Transcript Motley Fool
Nov-05-21 05:47AM	Bionano: On Course to Beat 2021 Saphyr Placement Guidance TipRanks -6.91%
Nov-04-21 08:56PM	Bionano Genomics, Inc. (BNGO) Reports Q3 Loss, Tops Revenue Estimates Zacks
04:05PM	Bionano Genomics Reports Third Quarter 2021 Financial Results and Highlights Recent Business Progress GlobeNewswire
08:00AM	Bionano Genomics Announces the Appointment of Stephanie Hoyle as VP Corporate Marketing and Alex Helm as VP Strategic Product Marketing GlobeNewswire
Nov-03-21 08:00AM	Bionano Genomics Announces Major Updates to Its Solve and Access Data Solutions Adding Significant New Variant Detection, Analysis and Reporting Capabilities for Optical Genome Mapping on the Saphyr® System GlobeNewswire
Nov-02-21 04:30PM	Bionano Genomics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire +12.59%
Nov-01-21 10:00AM	2 Best Biotech Stocks to Buy in November Motley Fool +6.30%
Oct-28-21 04:30PM	Bionano Genomics to Report Third Quarter 2021 Financial Results and Host a Conference Call and Webcast on November 4, 2021 GlobeNewswire

Bionano Genomics, Inc. provides genome analysis software solutions. It offers Saphyr, a sample-to-result solution for structural variation analysis by optical genome mapping for genome analysis and understanding of genetic variation and function; Saphyr instrument, a single-molecule imager; Saphyr Chip, a consumable that packages the nanochannel arrays for DNA linearization; and Bionano Prep Kits and DNA labeling kits, which provide the reagents and protocols for extracting and labeling ultra-high molecular weight. The company also provides Saphyr and Bionano compute servers; and NxClinical which offers one system for analysis and interpretation of genomic variants from microarray and next-generation sequencing data for cytogenetics and molecular genetics. In addition, it offers testing and laboratory services comprising FirstStepDx PLUS, a chromosomal microarray for identifying an underlying genetic cause in individuals with autism spectrum disorder, developmental delay, and intellectual disability; Fragile X syndrome (FXS) testing services; NextStepDx PLUS, a exome sequencing test to identify genetic variants that are associated with disorders of childhood development; EpiPanelDx PLUS, a genetic testing panel for patients who have experienced seizures, infantile spasms, encephalopathy, or febrile seizures; PGx test, which identifies over 60 alleles in 11 genes. The company was founded in 2003 and is headquartered in San Diego, California.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
BARKER DAVID L	Director	May 16	Buy	1.60	10,000	16,000	13,894	May 18 04:16 PM
Stewart Christopher P.	Chief Financial Officer	May 13	Option Exercise	0.56	60,000	33,600	121,579	May 16 09:31 PM
Holmlin R. Erik	President and CEO	Nov 29	Buy	3.99	5,025	20,037	5,025	Dec 01 06:00 AM
Stewart Christopher P.	Chief Financial Officer	Nov 19	Option Exercise	0.56	22,500	12,600	55,500	Nov 23 06:00 AM

open in yahoo | open in reuters | open in marketwatch | open in google

Upgrade your FINVIZ experience